Neurocrine Biosciences, Inc. (BVMF:N1BI34)
42.04
+1.48 (3.65%)
At close: Dec 5, 2025
8.80% (1Y)
| Market Cap | 83.92B |
| Revenue (ttm) | 14.30B |
| Net Income (ttm) | 2.28B |
| Shares Out | n/a |
| EPS (ttm) | 22.34 |
| PE Ratio | 36.79 |
| Forward PE | 16.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 66 |
| Average Volume | 1,358 |
| Open | 42.04 |
| Previous Close | 40.56 |
| Day's Range | 42.04 - 42.04 |
| 52-Week Range | 25.64 - 44.95 |
| Beta | 0.28 |
| RSI | 59.45 |
| Earnings Date | Feb 9, 2026 |